The influence of vasoactive agents on the perfusion of tumours growing in three sites in the mouse.
Hirst
D G
DG
CRC Gray Laboratory, Mount Vernon Hospital, Northwood, Middlesex, UK.
Hirst
V K
VK
Shaffi
K M
KM
Prise
V E
VE
Joiner
B
B
D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001783:Blood Flow Velocity / Q000187:drug effects; D006830:Hydralazine / Q000494:pharmacology; D008297:Male; D051379:Mice; D008808:Mice, Inbred CBA; D009368:Neoplasm Transplantation; D012701:Serotonin / Q000494:pharmacology; D012983:Soft Tissue Neoplasms / Q000098:blood supply*; D014662:Vasoconstrictor Agents / Q000494:pharmacology*; D014665:Vasodilator Agents / Q000494:pharmacology*
D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D000804:Angiotensin II; D006830:Hydralazine; D012701:Serotonin